These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38068538)

  • 1. Effectiveness of Early Direct Oral Anticoagulant Monotherapy within One Year of Coronary Stent Implantation in Patients with Atrial Fibrillation: A Nationwide Population-Based Study.
    Hwang Y; Park S; Kim S; Kim SH; Oh YS; Chang K; Choi Y
    J Clin Med; 2023 Dec; 12(23):. PubMed ID: 38068538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single direct oral anticoagulant therapy in stable patients with atrial fibrillation beyond 1 year after coronary stent implantation.
    Choi Y; Lee Y; Kim SH; Kim S; Kim JY; Kim TS; Hwang Y; Kim JH; Jang SW; Lee MY; Oh YS
    Heart; 2022 Feb; 108(4):285-291. PubMed ID: 33990409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antithrombotic treatment beyond 1 year after percutaneous coronary intervention in patients with atrial fibrillation.
    Jensen T; Thrane PG; Olesen KKW; Würtz M; Mortensen MB; Gyldenkerne C; Thim T; Nørgaard BL; Jensen JM; Kristensen SD; Nielsen JC; Eikelboom JW; Maeng M
    Eur Heart J Cardiovasc Pharmacother; 2023 Apr; 9(3):208-219. PubMed ID: 36269306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is percutaneous coronary intervention safe during uninterrupted direct oral anticoagulant therapy in patients with atrial fibrillation and acute coronary syndromes?
    De Luca L; Rubboli A; Bolognese L; Uguccioni M; Lucci D; Blengino S; Campodonico J; Meynet I; Brach Prever SM; Di Lenarda A; Gabrielli D; Gulizia MM;
    Open Heart; 2021 Jul; 8(2):. PubMed ID: 34261777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Direct Oral Anticoagulant Off-Label Reduced Dose in Combination With Antiplatelet Agents on Clinical Outcome　- Propensity Score-Matching Analysis From the DIRECT Real-World Non-Valvular Atrial Fibrillation Registry.
    Kobayashi T; Sotomi Y; Hirata A; Sakata Y; Hirayama A; Higuchi Y
    Circ Rep; 2020 Apr; 2(6):289-296. PubMed ID: 33693243
    [No Abstract]   [Full Text] [Related]  

  • 6. Prognosis of Atrial Fibrillation Patients Undergoing PCI According to Anticoagulants and Antiplatelet Agents.
    Yoon GS; Kim SH; Kang SH; Yoon CH; Cho YS; Youn TJ; Chae IH
    J Clin Med; 2021 Jul; 10(15):. PubMed ID: 34362151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Net clinical benefit of antithrombotic therapy for atrial fibrillation patients with stable coronary artery disease.
    Lee SR; Jung JH; Choi EK; Lee SW; Kwon S; Park JS; Kang J; Han KD; Park KW; Oh S; Lip GYH
    Front Cardiovasc Med; 2022; 9():991293. PubMed ID: 36072876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct Oral Anticoagulants Would Be Best Choice for Atrial Fibrillation Patients After Coronary Stenting: Retrospective Study in a Japanese Population.
    Koiwaya H; Watanabe N; Kuriyama N; Shibata Y
    Kurume Med J; 2023 Jul; 68(2):97-106. PubMed ID: 37100602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combining Oral Anticoagulants With Platelet Inhibitors in Patients With Atrial Fibrillation and Coronary Disease.
    Sindet-Pedersen C; Lamberts M; Staerk L; Nissen Bonde A; Berger JS; Pallisgaard JL; Lock Hansen M; Torp-Pedersen C; Gislason GH; Olesen JB
    J Am Coll Cardiol; 2018 Oct; 72(15):1790-1800. PubMed ID: 30286922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anticoagulation status and adherence in patients with atrial fibrillation hospitalized for ACS and the impact on 1-year prognosis: a multicenter cohort study].
    Zhu LY; Li Q; Yu LY; Liu Y; Chen YN; Wang Z; Zhang SY; Li J; Liu Y; Zhao YL; Xi Y; Pi L; Sun YH
    Zhonghua Xin Xue Guan Bing Za Zhi; 2023 Jul; 51(7):731-741. PubMed ID: 37460427
    [No Abstract]   [Full Text] [Related]  

  • 11. Advances in Antiplatelet and Anticoagulant Therapies for NSTE-ACS.
    Badjatiya A; Rao SV
    Curr Cardiol Rep; 2019 Jan; 21(1):3. PubMed ID: 30637536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-Hospital Bleeding Outcomes of Myocardial Infarction in the Era of Warfarin and Direct Oral Anticoagulants for Atrial Fibrillation in the United States: A Report From the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry.
    Feldman DN; Wang TY; Chen AY; Swaminathan RV; Kim LK; Wong SC; Minutello RM; Bergman G; Singh HS; Madias C
    J Am Heart Assoc; 2019 Apr; 8(8):e011606. PubMed ID: 30955406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy comparison of primary percutaneous coronary intervention by drug-coated balloon angioplasty or drug-eluting stenting in acute myocardial infarction patients with de novo coronary lesions].
    Zhang DP; Wang LF; Liu Y; Li KB; Xu L; Li WM; Ni ZH; Xia K; Zhang ZY; Yang XC
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Jul; 48(7):600-607. PubMed ID: 32842271
    [No Abstract]   [Full Text] [Related]  

  • 14. Intracranial haemorrhages vs. stent thromboses with direct oral anticoagulant plus single antiplatelet agent or triple antithrombotic therapy: a meta-analysis of randomized trials in atrial fibrillation and percutaneous coronary intervention/acute coronary syndrome patients.
    Galli M; Andreotti F; Porto I; Crea F
    Europace; 2020 Apr; 22(4):538-546. PubMed ID: 31942971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Impact of short-time anticoagulant therapy after selective percutaneous intervention on prognosis of patients with coronary artery disease].
    Song Y; Tang XF; Xu JJ; Wang HH; Liu R; Jiang P; Jiang L; Gao LJ; Zhang Y; Song L; Xu LJ; Zhao XY; Gao Z; Chen J; Gao RL; Qiao SB; Yang YJ; Xu B; Yuan JQ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Feb; 47(2):108-116. PubMed ID: 30818938
    [No Abstract]   [Full Text] [Related]  

  • 16. Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation implications for bleeding risk and prognosis.
    Ruiz-Nodar JM; Marín F; Hurtado JA; Valencia J; Pinar E; Pineda J; Gimeno JR; Sogorb F; Valdés M; Lip GY
    J Am Coll Cardiol; 2008 Feb; 51(8):818-25. PubMed ID: 18294566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical profile of direct oral anticoagulants versus vitamin K anticoagulants in octogenarians with atrial fibrillation: a multicentre propensity score matched real-world cohort study.
    Russo V; Attena E; Di Maio M; Mazzone C; Carbone A; Parisi V; Rago A; D'Onofrio A; Golino P; Nigro G
    J Thromb Thrombolysis; 2020 Jan; 49(1):42-53. PubMed ID: 31385163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual therapy with oral anticoagulation and single antiplatelet agent versus monotherapy with oral anticoagulation alone in patients with atrial fibrillation and stable ischemic heart disease: a systematic review and meta-analysis.
    Shakir A; Khan A; Agarwal S; Clifton S; Reese J; Munir MB; Nasir UB; Khan SU; Gopinathannair R; DeSimone CV; Deshmukh A; Jackman WM; Stavrakis S; Asad ZUA
    J Interv Card Electrophysiol; 2023 Mar; 66(2):493-506. PubMed ID: 36085242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antithrombotic therapy in atrial fibrillation patients with coronary artery disease: shifting paradigm to a "less is more" concept regimen.
    Kawakami S; Yasuda S; Ogawa H
    J Cardiol; 2020 Jul; 76(1):35-43. PubMed ID: 32389534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antithrombotic Therapy for Chronic Kidney Disease Patients With Concomitant Atrial Fibrillation and Coronary Artery Disease.
    Lee KH; Ou SM; Chu YC; Lin YP; Tsai MT; Tarng DC
    Front Cardiovasc Med; 2021; 8():751359. PubMed ID: 34692798
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.